author-photo

Mitsuharu Hashimura

5

Papers

2

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Azacitidine (AZA) Combination Therapy with Low-Dose AraC for Aggressive Type MDS, Overt AML, and AML Patients

2015 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Azacitidine (AZA) Combination Therapy with Low-Dose AraC Is Well Tolerated and Highly Effective for MDS with Overt Leukemia

2014 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A New Strategy Of MDS Treatment With Azacitidine (AZA): Induction With AZA Combined With Low Dose AraC Followed By Maintenance Therapy With AZA

2013 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Tolerated, Low-Dose Deferasirox: Successful Three Cases of Aplastic Anemia and 34 Cases of MDS

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)